Physician Portal

Physician Stories

SLT as a Primary Therapy for Glaucoma

According to glaucoma expert Andrew G. Iwach, MD, at the ASCRS 2013 in San Francisco, he and his colleagues have known for a long time that SLT delivers better IOP-reducing results when used as primary therapy.

SLT as Primary, Adjunct and Alternative Therapy for Glaucoma

SLT is a highly effective approach for first-line glaucoma treatments, as adjunct therapy with drugs, and as alternative therapy when drugs or surgery fail.

Bringing Down the Cost of Glaucoma Treatment with SLT

One of the biggest advantages of SLT is that, in addition to being an effective approach for first-line glaucoma treatment, as adjunct therapy with drugs, and as alternative therapy when drugs or surgery fail, it has also been found to be a more economical approach when compared to topical medications. In this video interview Randy E. Craven, MD, spotlights the many financial benefits of SLT for the patient — and for the wider healthcare system.

SLT Treatment Protocol

With one of the world’s largest SLT case studies – more than 4500 eyes treated – Lawrence F. Jindra is considered to be an expert in the use of SLT to treat glaucoma. In this video interview, Dr. Jindra highlights how to achieve the best results when using SLT to treat various types of glaucoma, and on various patient types.

SLT: The Standard of Care for Glaucoma

One of the biggest advantages of SLT is that, in addition to being an effectiveapproach for first-line glaucoma treatment, as adjunct therapy with drugs, and as alternative therapy when drugs or surgery fail, it also eliminates the compliance issues and ongoing expense of medications for the patient.

SLT and the Refractive Surgeon

The glaucoma medications used to control the IOP of refractive patients often add to the blurred vision experienced by these patients on a daily basis. This leaves the refractive surgeon with the frustrating task of correcting refractive error without being able to eliminate a key contributor to the problem. In this Video interview, Matahias Maus, MD, one of Germany’s leading refractive surgeons, addresses how SLT the role of SLT as an effective first-line glaucoma treatment for these patients, whilst eliminating the need for troublesome medications.

Achieving Versatility in Glaucoma Management

The effectiveness of SLT in treating open-angle glaucoma and ocular hypertension is well established. SLT can also be used to effectively treat pseudoexfoliation glaucoma, pigmentary glaucoma, normal tension glaucoma, pseudophakic glaucoma, and angle-closure glaucoma post-iridotomy – making it an extremely versatile tool in the glaucoma treatment armamentarium.

The Mechanism of Action of SLT

A number of theories have been proposed regarding the mechanism of action of Selective Laser Trabeculoplasty (SLT). Whilst SLT has been shown to achieve a similar therapeutic effect as Argon Laser Trabeculoplasty (ALT) in the treatment of glaucoma, the mechanical and biological effects differ markedly. Most importantly, SLT is able to achieve the desired therapeutic effect without the coagulative damage caused by ALT. Watch the video interview with Mr. Lim to learn more.

Predicting Success with SLT

Now that more physicians and patients have access to SLT, it is important to understand how this modality best fits into the management of patients with glaucoma. Since not all patients respond equally to SLT, isolating the factors that can help to determine the likelihood that a patient will respond successfully to treatment with SLT is an important step in glaucoma management.

SLT and the Glaucoma Surgeon

Not only can SLT achieve sustained IOP reduction for the majority of your glaucoma patients, but it has also been hypothesized to improve the prognosis of glaucoma surgery as compared to long-term medication use.

SLT in the Glaucoma Treatment Armamentarium

Long-term control of intraocular pressure (IOP) is key to minimizing the ocular damage that eventually occurs in glaucoma patients. The effects of traditional anti-glaucoma eyedrops are short-lived and therefore require diligent, long-term use. Even argon laser trabeculoplasty (ALT), which is known to deliver effective results, starts to lose efficacy within several years. In contrast, selective laser trabeculoplasty (SLT) delivers effective IOP reduction that lasts far longer than any other treatment.

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More